Although the study did not find any CYP2C9 variants associated with highly diminished THC metabolism, analysis of the AKT1 and COMT genotypes revealed that over half (> 55%) of the participants had gene variants that significantly increased their risk of potentially developing psychotic symptoms and/or cognitive impairment. Here, AKT1 is linked to Cognitive impairment.